PRAD is a prevalent cancer type in males, and multiple biomolecules that act as markers of PRAD are in common with COVID-19 (Both TMPRSS2 and CXCL10 were upregulated in PRAD patients). The gene discussed is CXCL10; the disease is prostate adenocarcinoma.